Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate in Indirect Neonatal Hyperbilirubinemia
NCT04868019Unknown
- Sponsor
- Shaheed Zulfiqar Ali Bhutto Medical University
- Start
- Sep 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in neonatal hyperbilirubinemia comparing Group A (Fenofibrate) with Group B (Placebo) (2 arms). Primary endpoint: Duration of phototherapy at 6 months. Status: unknown.
02
Drugs
fenofibrate
03
Conditions
neonatal hyperbilirubinemia
Beyond the preview
Go deeper on NCT04868019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04868019.